Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 3,743 shares at $62.50 ($241K) on 2021-05-05, disclosed to the SEC on 2021-05-05.
Open-market sale of $241k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.03 | 1,257 | $86K | 35.5% |
| 2 | $62.50 | 1,243 | $78K | 32.3% |
| 3 | $62.50 | 1,243 | $78K | 32.3% |
| Total | $64.36 avg | 3,743 | $241K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |